Troubleshooting Common Pitfalls of 2-Stent Strategies
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Consultant Fee/Honoraria/Speaker's Bureau - Abbott; Boston Scientific Corporation; CSI; GE Healthcare; Medtronic; Siemens; Teleflex; Biotronik; Opsens; IMDS; Medicure; Asahi; Amgen; Terumo Medical Corporation
- Royalty/Intellectual Property Rights - Elsevier
- Equity/Stock(s)/Options - MHI Ventures; Stallion Medical; Hippocrates LLC; Cleerly Health
- Grant Support/Research Contract - Boston Scientific Corporation; GE Healthcare